Arcus Biosciences Operating Margin 2017-2024 | RCUS

Current and historical operating margin for Arcus Biosciences (RCUS) over the last 10 years. The current operating profit margin for Arcus Biosciences as of June 30, 2024 is -102.66%.
Arcus Biosciences Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2024-06-30 $0.25B $-0.29B -118.62%
2024-03-31 $0.24B $-0.27B -113.92%
2023-12-31 $0.12B $-0.34B -290.60%
2023-09-30 $0.12B $-0.32B -269.17%
2023-06-30 $0.12B $-0.31B -258.68%
2023-03-31 $0.12B $-0.30B -251.26%
2022-12-31 $0.11B $-0.28B -250.00%
2022-09-30 $0.43B $0.08B 17.32%
2022-06-30 $0.41B $0.07B 16.38%
2022-03-31 $0.39B $0.06B 15.35%
2021-12-31 $0.38B $0.05B 14.14%
2021-09-30 $0.04B $-0.28B -754.05%
2021-06-30 $0.09B $-0.20B -213.98%
2021-03-31 $0.09B $-0.17B -195.35%
2020-12-31 $0.08B $-0.12B -155.70%
2020-09-30 $0.08B $-0.09B -112.66%
2020-06-30 $0.02B $-0.11B -712.50%
2020-03-31 $0.02B $-0.10B -612.50%
2019-12-31 $0.02B $-0.09B -556.25%
2019-09-30 $0.01B $-0.08B -1050.00%
2019-06-30 $0.01B $-0.07B -730.00%
2019-03-31 $0.01B $-0.06B -666.67%
2018-12-31 $0.01B $-0.05B -675.00%
2018-09-30 $0.01B $-0.05B -771.43%
2018-06-30 $0.00B $-0.07B -2166.67%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.624B $0.117B
Arcus Biosciences is a biopharmaceutical company. It focused on creating innovative cancer immunotherapies. The company's product portfolio includes AB928, AB122, AB154 and AB680. AB928 which is in its final phase is a potent and selective dual antagonist of the adenosine receptors. AB122 which is in its Phase1 is a monoclonal antibody which potently and selectively blocks a protein called PD-1. AB154 is a monoclonal antibody which potently and selectively blocks a novel immune checkpoint called TIGIT. AB680, which is in its Phase1 is a potent and selective inhibitor of CD73, the enzyme responsible for the extracellular production of adenosine within the tumor micro-environment. Arcus Biosciences is based in Hayward, CA.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $172.983B 16.74
Vertex Pharmaceuticals (VRTX) United States $129.208B 0.00
Bristol Myers Squibb (BMY) United States $121.326B 51.13
Gilead Sciences (GILD) United States $120.802B 21.90
CSL (CSLLY) Australia $91.515B 0.00
Regeneron Pharmaceuticals (REGN) United States $90.734B 20.65
GSK (GSK) United Kingdom $75.337B 8.72
Alnylam Pharmaceuticals (ALNY) United States $36.091B 0.00
Argenex SE (ARGX) Netherlands $35.216B 0.00
BioNTech SE (BNTX) Germany $26.067B 0.00
Biogen (BIIB) United States $25.068B 10.77
Illumina (ILMN) United States $24.028B 87.57
BeiGene (BGNE) Cayman Islands $19.970B 0.00
Moderna (MRNA) United States $16.451B 0.00
Incyte (INCY) United States $15.707B 0.00
Genmab (GMAB) Denmark $15.353B 22.52
Vaxcyte (PCVX) United States $12.917B 0.00
Insmed (INSM) United States $12.849B 0.00
BioMarin Pharmaceutical (BMRN) United States $12.649B 29.37
Bio-Techne Corp (TECH) United States $11.868B 45.82
Sarepta Therapeutics (SRPT) United States $11.256B 101.59
Exelixis (EXEL) United States $10.335B 23.50
Revolution Medicines (RVMD) United States $10.194B 0.00
QIAGEN (QGEN) Netherlands $10.052B 20.68
Intra-Cellular Therapies (ITCI) United States $9.708B 0.00
Exact Sciences (EXAS) United States $9.500B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.375B 31.86
Roivant Sciences (ROIV) United Kingdom $8.734B 0.00
Repligen (RGEN) United States $7.813B 119.24
Ascendis Pharma (ASND) Denmark $7.786B 0.00
Halozyme Therapeutics (HALO) United States $7.772B 17.56
Legend Biotech (LEGN) United States $7.300B 0.00
Viking Therapeutics (VKTX) United States $7.017B 0.00
Cytokinetics (CYTK) United States $6.918B 0.00
Blueprint Medicines (BPMC) United States $6.344B 0.00
Nuvalent (NUVL) United States $6.116B 0.00
Arcellx (ACLX) United States $5.761B 0.00
Krystal Biotech (KRYS) United States $5.633B 93.27
Avidity Biosciences (RNA) United States $5.622B 0.00
ADMA Biologics Inc (ADMA) United States $5.240B 56.20
Biohaven (BHVN) United States $4.957B 0.00
Alkermes (ALKS) Ireland $4.866B 16.34
Ultragenyx Pharmaceutical (RARE) United States $4.685B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.682B 0.00
Immunovant (IMVT) United States $4.571B 0.00
Denali Therapeutics (DNLI) United States $4.545B 0.00
Axsome Therapeutics (AXSM) United States $4.321B 0.00
Rhythm Pharmaceuticals (RYTM) United States $4.030B 0.00
ImmunityBio (IBRX) United States $3.796B 0.00
Apellis Pharmaceuticals (APLS) United States $3.680B 0.00
Guardant Health (GH) United States $3.628B 0.00
Merus (MRUS) Netherlands $3.626B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.443B 0.00
Kymera Therapeutics (KYMR) United States $3.357B 0.00
Edgewise Therapeutics (EWTX) United States $3.345B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.339B 0.00
Iovance Biotherapeutics (IOVA) United States $3.246B 0.00
Amicus Therapeutics (FOLD) United States $3.194B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $3.187B 0.00
Zai Lab (ZLAB) China $3.097B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.075B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.040B 23.42
Janux Therapeutics (JANX) United States $2.817B 0.00
Vericel (VCEL) United States $2.803B 946.33
Protagonist Therapeutics (PTGX) United States $2.771B 17.48
Twist Bioscience (TWST) United States $2.770B 0.00
IDEAYA Biosciences (IDYA) United States $2.764B 0.00
Keros Therapeutics (KROS) United States $2.761B 0.00
Apogee Therapeutics (APGE) United States $2.721B 0.00
Vera Therapeutics (VERA) United States $2.668B 0.00
CG Oncology (CGON) United States $2.662B 0.00
Beam Therapeutics (BEAM) United States $2.513B 0.00
Geron (GERN) United States $2.491B 0.00
SpringWorks Therapeutics (SWTX) United States $2.490B 0.00
Belite Bio (BLTE) United States $2.407B 0.00
Ligand Pharmaceuticals (LGND) United States $2.333B 58.24
Longboard Pharmaceuticals (LBPH) United States $2.325B 0.00
Bavarian Nordic (BVNRY) Denmark $2.318B 12.40
Akero Therapeutics (AKRO) United States $2.306B 0.00
Scholar Rock Holding (SRRK) United States $2.253B 0.00
Structure Therapeutics (GPCR) United States $2.214B 0.00
Neumora Therapeutics (NMRA) United States $2.183B 0.00
NeoGenomics (NEO) United States $2.099B 0.00
WAVE Life Sciences (WVE) Singapore $2.051B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.048B 17.02
Fortrea Holdings (FTRE) United States $2.041B 65.00
Spyre Therapeutics (SYRE) United States $2.024B 0.00
Nurix Therapeutics (NRIX) United States $1.993B 0.00
MannKind (MNKD) United States $1.991B 51.57
Mirum Pharmaceuticals (MIRM) United States $1.985B 0.00
Disc Medicine (IRON) United States $1.979B 0.00
NovoCure (NVCR) Jersey $1.968B 0.00
Arvinas (ARVN) United States $1.927B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.867B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.859B 0.00
Galapagos (GLPG) Belgium $1.844B 0.00
Dynavax Technologies (DVAX) United States $1.796B 105.08
Intellia Therapeutics (NTLA) United States $1.782B 0.00
Certara (CERT) United States $1.753B 49.50
Celldex Therapeutics (CLDX) United States $1.739B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.733B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.664B 0.00
Viridian Therapeutics (VRDN) United States $1.643B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.599B 0.00
Praxis Precision Medicines (PRAX) United States $1.581B 0.00
Myriad Genetics (MYGN) United States $1.576B 0.00
Gyre Therapeutics (GYRE) United States $1.570B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.537B 0.00
Travere Therapeutics (TVTX) United States $1.485B 0.00
Novavax (NVAX) United States $1.442B 0.00
Upstream Bio (UPB) United States $1.436B 0.00
Kura Oncology (KURA) United States $1.366B 0.00
Vir Biotechnology (VIR) United States $1.359B 0.00
ANI Pharmaceuticals (ANIP) United States $1.299B 17.69
Arcutis Biotherapeutics (ARQT) United States $1.269B 0.00
Bicara Therapeutics (BCAX) United States $1.248B 0.00
Zymeworks (ZYME) United States $1.194B 0.00
Applied Therapeutics (APLT) United States $1.191B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.157B 0.00
ArriVent BioPharma (AVBP) United States $1.153B 0.00
Cogent Biosciences (COGT) United States $1.138B 0.00
MiMedx (MDXG) United States $1.123B 29.39
Mesoblast (MESO) Australia $1.112B 0.00
Immatics (IMTX) Germany $1.079B 0.00
Septerna (SEPN) $1.069B 0.00
89BIO (ETNB) United States $1.067B 0.00
CARGO Therapeutics (CRGX) United States $1.009B 0.00
Cullinan Therapeutics (CGEM) United States $1.006B 0.00
Rapport Therapeutics (RAPP) United States $0.984B 0.00
LENZ Therapeutics (LENZ) United States $0.983B 0.00
Prothena (PRTA) Ireland $0.972B 0.00
Adaptive Biotechnologies (ADPT) United States $0.958B 0.00
Castle Biosciences (CSTL) United States $0.946B 168.90
Autolus Therapeutics (AUTL) United Kingdom $0.934B 0.00
AbCellera Biologics (ABCL) Canada $0.930B 0.00
Neurogene (NGNE) United States $0.929B 0.00
Cytek Biosciences (CTKB) United States $0.921B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.896B 0.00
Pliant Therapeutics (PLRX) United States $0.883B 0.00
Erasca (ERAS) United States $0.879B 0.00
Replimune (REPL) United States $0.854B 0.00
Zenas BioPharma (ZBIO) United States $0.846B 0.00
Liquidia Technologies (LQDA) United States $0.824B 0.00
Dianthus Therapeutics (DNTH) United States $0.821B 0.00
Tyra Biosciences (TYRA) United States $0.821B 0.00
BioAge Labs (BIOA) United States $0.813B 0.00
Pacira BioSciences (PCRX) United States $0.808B 7.61
Immunome (IMNM) United States $0.796B 0.00
MBX Biosciences (MBX) United States $0.785B 0.00
Avid Bioservices (CDMO) United States $0.781B 0.00
Anavex Life Sciences (AVXL) United States $0.776B 0.00
IGM Biosciences (IGMS) United States $0.764B 0.00
Nuvation Bio (NUVB) United States $0.750B 0.00
Entrada Therapeutics (TRDA) United States $0.744B 12.51
Mineralys Therapeutics (MLYS) United States $0.742B 0.00
Annexon (ANNX) United States $0.736B 0.00
Stoke Therapeutics (STOK) United States $0.731B 0.00
CorMedix Inc (CRMD) United States $0.731B 0.00
Olema Pharmaceuticals (OLMA) United States $0.728B 0.00
Oric Pharmaceuticals (ORIC) United States $0.727B 0.00
Arbutus Biopharma (ABUS) United States $0.707B 0.00
Third Harmonic Bio (THRD) United States $0.694B 0.00
AnaptysBio (ANAB) United States $0.682B 0.00
Tectonic Therapeutic (TECX) United States $0.679B 0.00
Astria Therapeutics (ATXS) United States $0.669B 0.00
Abivax SA (ABVX) France $0.668B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.666B 0.00
Humacyte (HUMA) United States $0.659B 0.00
Emergent Biosolutions (EBS) United States $0.649B 0.00
Allogene Therapeutics (ALLO) United States $0.648B 0.00
Oculis Holding AG (OCS) Switzerland $0.648B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.647B 0.00
Sana Biotechnology (SANA) United States $0.645B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.642B 0.00
CureVac (CVAC) Germany $0.625B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.615B 0.00
ACELYRIN, INC (SLRN) United States $0.605B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.598B 0.00
Alector (ALEC) United States $0.593B 0.00
Celcuity (CELC) United States $0.581B 0.00
REGENXBIO (RGNX) United States $0.573B 0.00
Sangamo Therapeutics (SGMO) United States $0.562B 0.00
Alumis (ALMS) United States $0.559B 0.00
Aura Biosciences (AURA) United States $0.553B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.552B 0.00
Q32 Bio (QTTB) United States $0.548B 0.00
PureTech Health (PRTC) United States $0.543B 0.00
Pharming Group (PHAR) Netherlands $0.542B 0.00
ChromaDex (CDXC) United States $0.535B 701.00
Prime Medicine (PRME) United States $0.527B 0.00
Terns Pharmaceuticals (TERN) United States $0.525B 0.00
Foghorn Therapeutics (FHTX) United States $0.516B 0.00
Cartesian Therapeutics (RNAC) United States $0.503B 0.00
Contineum Therapeutics (CTNM) United States $0.497B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.491B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.487B 0.00
Absci (ABSI) United States $0.486B 0.00
GRAIL (GRAL) United States $0.475B 0.00
GH Research (GHRS) Ireland $0.470B 0.00
MeiraGTx Holdings (MGTX) United States $0.461B 0.00
C4 Therapeutics (CCCC) United States $0.415B 0.00
Northwest Biotherapeutics (NWBO) United States $0.414B 0.00
BioStem Technologies (BSEM) $0.411B 63.38
Alpha Teknova (TKNO) United States $0.403B 0.00
Voyager Therapeutics (VYGR) United States $0.382B 25.04
MaxCyte (MXCT) United States $0.378B 0.00
Design Therapeutics (DSGN) United States $0.374B 0.00
Jasper Therapeutics (JSPR) United States $0.374B 0.00
UniQure (QURE) Netherlands $0.373B 0.00
XOMA Royalty (XOMA) United States $0.367B 0.00
EnGene Holdings (ENGN) Canada $0.365B 0.00
Tango Therapeutics (TNGX) United States $0.363B 0.00
Revance Therapeutics (RVNC) United States $0.362B 0.00
Poseida Therapeutics (PSTX) United States $0.362B 0.00
Sutro Biopharma (STRO) United States $0.361B 0.00
Kamada (KMDA) Israel $0.351B 22.59
Rezolute (RZLT) United States $0.345B 0.00
ITeos Therapeutics (ITOS) United States $0.343B 0.00
Codexis (CDXS) United States $0.330B 0.00
Artiva Biotherapeutics (ARTV) United States $0.325B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.323B 0.00
Zura Bio (ZURA) United States $0.317B 0.00
AC Immune (ACIU) Switzerland $0.314B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.313B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.311B 0.00
Mersana Therapeutics (MRSN) United States $0.310B 0.00
Ocugen (OCGN) United States $0.308B 0.00
Nautilus Biotechnology (NAUT) United States $0.304B 0.00
TScan Therapeutics (TCRX) United States $0.302B 0.00
Urogen Pharma (URGN) United States $0.300B 0.00
Fate Therapeutics (FATE) United States $0.292B 0.00
Biomea Fusion (BMEA) United States $0.291B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.288B 0.00
Prima BioMed (IMMP) Australia $0.288B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.287B 0.00
Atea Pharmaceuticals (AVIR) United States $0.284B 0.00
ATyr Pharma (ATYR) United States $0.282B 0.00
Kodiak Sciences (KOD) United States $0.281B 0.00
Abeona Therapeutics (ABEO) United States $0.279B 0.00
Editas Medicine (EDIT) United States $0.272B 0.00
Climb Bio (CLYM) United States $0.272B 0.00
Compass Therapeutics (CMPX) United States $0.261B 0.00
GENFIT S.A (GNFT) France $0.261B 0.00
Inozyme Pharma (INZY) United States $0.257B 0.00
Precigen (PGEN) United States $0.253B 0.00
Caribou Biosciences (CRBU) United States $0.253B 0.00
Eton Pharmaceuticals (ETON) United States $0.251B 0.00
Anika Therapeutics (ANIK) United States $0.250B 0.00
Opthea (OPT) Australia $0.246B 0.00
Lifecore Biomedical (LFCR) United States $0.241B 0.00
Solid Biosciences (SLDB) United States $0.239B 0.00
Nkarta (NKTX) United States $0.239B 0.00
Kyverna Therapeutics (KYTX) United States $0.239B 0.00
Semper Paratus Acquisition (TVGN) United States $0.237B 0.00
2seventy Bio (TSVT) United States $0.237B 0.00
Trevi Therapeutics (TRVI) United States $0.236B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.232B 0.00
Inhibrx Biosciences (INBX) United States $0.232B 0.00
Amarin (AMRN) Ireland $0.230B 0.00
Fulcrum Therapeutics (FULC) United States $0.227B 0.00
XBiotech (XBIT) United States $0.222B 0.00
Instil Bio (TIL) United States $0.219B 0.00
Cabaletta Bio (CABA) United States $0.218B 0.00
Molecular Partners AG (MOLN) Switzerland $0.214B 0.00
ScPharmaceuticals (SCPH) United States $0.212B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.211B 0.00
Nuvectis Pharma (NVCT) United States $0.209B 0.00
CAMP4 Therapeutics (CAMP) United States $0.205B 0.00
Tenaya Therapeutics (TNYA) United States $0.204B 0.00
Verastem (VSTM) United States $0.199B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.197B 0.00
Bright Minds Biosciences (DRUG) United States $0.196B 0.00
Gossamer Bio (GOSS) United States $0.194B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.193B 0.00
Black Diamond Therapeutics (BDTX) United States $0.191B 0.00
Greenwich LifeSciences (GLSI) United States $0.185B 0.00
DiaMedica Therapeutics (DMAC) United States $0.181B 0.00
Sagimet Biosciences (SGMT) United States $0.179B 0.00
Cardiff Oncology (CRDF) United States $0.177B 0.00
Actuate Therapeutics (ACTU) United States $0.175B 0.00
Skye Bioscience (SKYE) United States $0.167B 0.00
PepGen (PEPG) United States $0.163B 0.00
Puma Biotechnology (PBYI) United States $0.162B 6.88
Adverum Biotechnologies (ADVM) United States $0.161B 0.00
Akoya Biosciences (AKYA) United States $0.159B 0.00
Repare Therapeutics (RPTX) Canada $0.157B 0.00
Compugen (CGEN) Israel $0.155B 0.00
Scilex Holding (SCLX) United States $0.154B 0.00
Oncobiologics (OTLK) United States $0.153B 0.00
Ventyx Biosciences (VTYX) United States $0.152B 0.00
Vigil Neuroscience (VIGL) United States $0.151B 0.00
Innate Pharma S.A (IPHA) France $0.150B 0.00
Candel Therapeutics (CADL) United States $0.149B 0.00
Generation Bio (GBIO) United States $0.146B 0.00
Checkpoint Therapeutics (CKPT) United States $0.144B 0.00
Inventiva S.A (IVA) France $0.142B 0.00
Rani Therapeutics Holdings (RANI) United States $0.140B 0.00
Inovio Pharmaceuticals (INO) United States $0.139B 0.00
Seer (SEER) United States $0.138B 0.00
INmune Bio (INMB) United States $0.136B 0.00
Allakos (ALLK) United States $0.134B 0.00
Alto Neuroscience (ANRO) United States $0.130B 0.00
Elutia (ELUT) United States $0.129B 0.00
Coya Therapeutics (COYA) United States $0.122B 0.00
FibroBiologics (FBLG) United States $0.121B 0.00
PDS Biotechnology (PDSB) United States $0.120B 0.00
Seres Therapeutics (MCRB) United States $0.118B 0.00
Adherex Technologies (FENC) United States $0.117B 0.00
Invivyd (IVVD) United States $0.117B 0.00
BioAtla (BCAB) United States $0.115B 0.00
Benitec Biopharma (BNTC) United States $0.113B 0.00
23andMe Holding (ME) United States $0.113B 0.00
X4 Pharmaceuticals (XFOR) United States $0.112B 0.00
Immunic (IMUX) United States $0.111B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.107B 0.00
Adagene (ADAG) China $0.107B 0.00
Cellectis S.A (CLLS) France $0.106B 0.00
Annovis Bio (ANVS) United States $0.106B 0.00
Adlai Nortye (ANL) Cayman Islands $0.105B 0.00
Adicet Bio (ACET) United States $0.104B 0.00
Genelux (GNLX) United States $0.104B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.103B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.100B 0.00
Renovaro (RENB) United States $0.100B 0.00
HilleVax (HLVX) United States $0.098B 0.00
Werewolf Therapeutics (HOWL) United States $0.098B 0.00
Ovid Therapeutics (OVID) United States $0.097B 0.00
Cidara Therapeutics (CDTX) United States $0.094B 0.00
BioHarvest Sciences (CNVCF) Canada $0.094B 0.00
Chimerix (CMRX) United States $0.094B 0.00
Cue Biopharma (CUE) United States $0.091B 0.00
InflaRx (IFRX) Germany $0.090B 0.00
Coherus BioSciences (CHRS) United States $0.090B 0.00
I-Mab (IMAB) China $0.090B 0.00
Genenta Science S.p.A (GNTA) Italy $0.089B 0.00
Monopar Therapeutics (MNPR) United States $0.088B 0.00
Syros Pharmaceuticals (SYRS) United States $0.087B 0.00
Ikena Oncology (IKNA) United States $0.084B 0.00
Agenus (AGEN) United States $0.084B 0.00
VistaGen Therapeutics (VTGN) United States $0.084B 0.00
Leap Therapeutics (LPTX) United States $0.084B 0.00
Oncolytics Biotech (ONCY) Canada $0.083B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.082B 0.00
Clearside Biomedical (CLSD) United States $0.081B 0.00
CytomX Therapeutics (CTMX) United States $0.081B 6.12
Galena Biopharma (SLS) United States $0.080B 0.00
Boundless Bio (BOLD) United States $0.080B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.079B 0.00
Bluebird Bio (BLUE) United States $0.079B 0.00
ALX Oncology Holdings (ALXO) United States $0.078B 0.00
ZIVO Bioscience (ZIVO) United States $0.078B 0.00
Aileron Therapeutics (ALRN) United States $0.078B 0.00
BeyondSpring (BYSI) United States $0.077B 0.00
Aerovate Therapeutics (AVTE) United States $0.076B 0.00
Celularity (CELU) United States $0.075B 0.00
MediciNova (MNOV) United States $0.075B 0.00
CervoMed (CRVO) United States $0.075B 0.00
TELA Bio (TELA) United States $0.073B 0.00
Quince Therapeutics (QNCX) United States $0.072B 0.00
Spero Therapeutics (SPRO) United States $0.072B 3.24
Vor Biopharma (VOR) $0.069B 0.00
IO Biotech (IOBT) Denmark $0.069B 0.00
DBV Technologies S.A (DBVT) France $0.065B 0.00
Precision BioSciences (DTIL) United States $0.064B 0.00
Rapt Therapeutics (RAPT) United States $0.061B 0.00
Entera Bio (ENTX) Israel $0.061B 0.00
Omega Therapeutics (OMGA) United States $0.060B 0.00
Enzo Biochem (ENZ) United States $0.060B 0.00
OnKure Therapeutics (OKUR) United States $0.059B 0.00
Affimed (AFMD) Germany $0.058B 0.00
Connect Biopharma Holdings (CNTB) United States $0.058B 0.00
Theratechnologies (THTX) Canada $0.058B 0.00
Atara Biotherapeutics (ATRA) United States $0.058B 0.00
Immuneering (IMRX) United States $0.056B 0.00
Shattuck Labs (STTK) United States $0.056B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.055B 0.00
Elicio Therapeutics (ELTX) United States $0.054B 0.00
Kezar Life Sciences (KZR) United States $0.054B 0.00
Kronos Bio (KRON) United States $0.053B 0.00
Aadi Bioscience (AADI) United States $0.052B 0.00
BGM Group (BGM) China $0.051B 0.00
Imunon (IMNN) United States $0.050B 0.00
Immix Biopharma (IMMX) United States $0.049B 0.00
Xilio Therapeutics (XLO) United States $0.048B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.046B 0.00
Aligos Therapeutics (ALGS) United States $0.045B 0.00
HOOKIPA Pharma (HOOK) United States $0.045B 0.00
Intensity Therapeutics (INTS) United States $0.044B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.044B 0.00
Rallybio (RLYB) United States $0.044B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.043B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.042B 0.00
Passage Bio (PASG) United States $0.040B 0.00
Fortress Biotech (FBIO) United States $0.040B 0.00
Elevation Oncology (ELEV) United States $0.040B 0.00
VTv Therapeutics (VTVT) United States $0.039B 0.00
NextCure (NXTC) United States $0.038B 0.00
Lantern Pharma (LTRN) United States $0.038B 0.00
Lumos Pharma (LUMO) United States $0.038B 0.00
CalciMedica (CALC) United States $0.038B 0.00
Dare Bioscience (DARE) United States $0.038B 0.00
Clene (CLNN) United States $0.037B 0.00
OKYO Pharma (OKYO) $0.037B 0.00
Lexaria Bioscience (LEXX) Canada $0.037B 0.00
KALA BIO (KALA) United States $0.034B 0.00
AN2 Therapeutics (ANTX) United States $0.033B 0.00
Longeveron (LGVN) United States $0.031B 0.00
Dyadic (DYAI) United States $0.031B 0.00
Grace Therapeutics (GRCE) Canada $0.031B 0.00
Opus Genetics (IRD) United States $0.031B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.030B 0.00
Eyenovia (EYEN) United States $0.030B 0.00
MiNK Therapeutics (INKT) United States $0.030B 0.00
Promis Neurosciences (PMN) Canada $0.030B 0.00
SAB Biotherapeutics (SABS) United States $0.029B 0.00
BioXcel Therapeutics (BTAI) United States $0.029B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.028B 0.00
Pluri (PLUR) Israel $0.028B 0.00
RenovoRx (RNXT) United States $0.028B 0.00
Estrella Immunopharma (ESLA) United States $0.028B 0.00
Equillium (EQ) United States $0.027B 0.00
GeoVax Labs (GOVX) United States $0.026B 0.00
Ocean Biomedical (OCEA) United States $0.026B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.026B 0.00
Femasys (FEMY) United States $0.026B 0.00
Curis (CRIS) United States $0.026B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.025B 0.00
Athira Pharma (ATHA) United States $0.025B 0.00
Bolt Biotherapeutics (BOLT) United States $0.024B 0.00
BRIACELL THERAP (BCTX) Canada $0.024B 0.00
Lisata Therapeutics (LSTA) United States $0.024B 0.00
Beyond Air (XAIR) United States $0.024B 0.00
Bionano Genomics (BNGO) United States $0.024B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.023B 0.00
Chemomab Therapeutics (CMMB) Israel $0.023B 0.00
LakeShore Biopharma (LSB) China $0.023B 0.00
Spruce Biosciences (SPRB) United States $0.022B 0.00
Gelteq (GELS) $0.022B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.021B 0.00
UNITY Biotechnology (UBX) United States $0.021B 0.00
Cyclo Therapeutics (CYTH) United States $0.020B 0.00
Cognition Therapeutics (CGTX) United States $0.020B 0.00
Aprea Therapeutics (APRE) United States $0.019B 0.00
Cadrenal Therapeutics (CVKD) United States $0.019B 0.00
Cara Therapeutics (CARA) United States $0.019B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.018B 0.00
Novogen (KZIA) Australia $0.018B 0.00
BioAffinity Technologies (BIAF) United States $0.018B 0.00
Cocrystal Pharma (COCP) United States $0.018B 0.00
Tenax Therapeutics (TENX) United States $0.017B 0.00
Synlogic (SYBX) United States $0.017B 0.00
IN8bio (INAB) United States $0.016B 0.00
Cingulate (CING) United States $0.015B 0.00
HCW Biologics (HCWB) United States $0.014B 0.00
Sensei Biotherapeutics (SNSE) United States $0.014B 0.00
Evaxion Biotech (EVAX) Denmark $0.014B 0.00
Apollomics (APLM) United States $0.013B 0.00
COSCIENS Biopharma (CSCI) Canada $0.012B 0.00
Turnstone Biologics (TSBX) United States $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
Aytu BioPharma (AYTU) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Evogene (EVGN) Israel $0.010B 0.00
Vincerx Pharma (VINC) United States $0.010B 0.00
Senti Biosciences (SNTI) United States $0.010B 0.00
Biora Therapeutics (BIOR) United States $0.010B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.010B 0.00
Mustang Bio (MBIO) United States $0.010B 0.00
NKGen Biotech (NKGN) United States $0.010B 0.00
Galecto (GLTO) Denmark $0.009B 0.00
Soligenix (SNGX) United States $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.008B 0.00
TuHURA Biosciences (HURA) United States $0.008B 0.00
Forte Biosciences (FBRX) United States $0.008B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.008B 0.00
GT Biopharma (GTBP) United States $0.008B 0.00
Edesa Biotech (EDSA) Canada $0.008B 0.00
Pulmatrix (PULM) United States $0.008B 0.00
Moleculin Biotech (MBRX) United States $0.008B 0.00
Quantum Biopharma (QNTM) Canada $0.007B 0.00
Cyclerion Therapeutics (CYCN) United States $0.007B 0.00
Aptose Biosciences (APTO) Canada $0.007B 0.00
ABVC BioPharma (ABVC) United States $0.007B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.006B 0.00
Adial Pharmaceuticals (ADIL) United States $0.006B 0.00
TFF Pharmaceuticals (TFFP) United States $0.006B 0.00
Bionomics (BNOX) Australia $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Organovo Holdings (ONVO) United States $0.006B 0.00
Eterna Therapeutics (ERNA) United States $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.006B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
Alzamend Neuro (ALZN) United States $0.006B 0.00
Carmell (CTCX) United States $0.006B 0.00
Vaccinex (VCNX) United States $0.006B 0.00
Exicure (XCUR) United States $0.005B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.005B 0.00
BioCardia (BCDA) United States $0.005B 0.00
Psyence Biomedical (PBM) Canada $0.005B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.005B 0.00
Polyrizon (PLRZ) $0.005B 0.00
Dogwood Therapeutics (DWTX) United States $0.005B 0.00
Biofrontera (BFRI) United States $0.005B 0.00
Portage Biotech (PRTG) $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
NuCana (NCNA) United Kingdom $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
AquaBounty Technologies (AQB) United States $0.004B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.004B 0.00
Silexion Therapeutics Corp (SLXN) United States $0.004B 0.00
Genetic Technologies (GENE) Australia $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.004B 0.00
GENPREX (GNPX) United States $0.003B 0.00
Pasithea Therapeutics (KTTA) United States $0.003B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
180 Life Sciences (ATNF) United States $0.003B 0.00
NAYA Biosciences (NAYA) United States $0.003B 0.00
Tharimmune (THAR) United States $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.003B 0.00
Sunshine Biopharma (SBFM) United States $0.003B 0.00
Citius Oncology (CTOR) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.003B 0.00
GRI Bio (GRI) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Allarity Therapeutics (ALLR) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Revelation Biosciences (REVB) United States $0.002B 0.00
Onconetix (ONCO) United States $0.001B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.001B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.001B 0.00
Elevai Labs (ELAB) United States $0.000B 0.00
Windtree Therapeutics (WINT) United States $0.000B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) Luxembourg $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
NeuBase Therapeutics (NBSE) United States $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00